-
RNA-Nanoparticle Spray Protects Against Plant Viruses
Plant scientists combined synthetic genetic material with clay nanoparticles, which when sprayed on plants provides enduring protection against viruses.
-
MD Anderson, Investment Firm Create Cancer Start-Up
MD Anderson Cancer Center and health care investment enterprise Deerfield Management are starting a new company to develop treatments for cancer that tackle processes feeding tumor growth.
-
Wearable Device Senses Environment for Sight Impaired
A research lab in Finland designed a wearable device using radar to help people with impaired sight sense other people and objects when outdoors.
-
Scripps, Pfizer Collaborate on DNA-Coded Drug Discovery
Drug maker Pfizer Inc. is gaining access to advances in a synthetic chemistry technology developed by Scripps Research Institute that tags compounds with DNA identifiers.
-
Neurology Drug Signals Shown to Help Tooth Repair
Chemical signals from a drug designed to treat Alzheimer’s disease and other neurological disorders were shown in tests with mice to stimulate stem cells that repair teeth.
-
Illumina Partnering with IBM, Phillips on Genomics Tools
Genomics technology company Illumina Inc. is collaborating with technology enterprises IBM and Royal Phillips to expand its sequencing services in precision medicine for cancer.
-
Sanofi Licensing Antibody for Autoimmune Diseases
The global drug company Sanofi is licensing a synthetic antibody to treat autoimmune disorders being developed by a spin-off enterprise from Dartmouth College.
-
MD Anderson Cutting Staff by 1,000
University of Texas – MD Anderson Cancer Center in Houston says it is cutting its workforce by about 1,000, about 5 percent of its staff. Most of the cuts, 800 to 900 jobs, will be done by layoffs.
-
Ionis Options Cardiac Drugs in $1.5 Billion Deal
Biotechnology company Ionis Pharmaceuticals is providing drug maker Novartis first access to two experimental drugs for controlling proteins that promote cholesterol and triglycerides, which contribute to heart disease.
-
Precision Health Tech Network Expands, Invests $400M
Digital Life Alliance, a consortium of enterprises applying advanced technologies to health and medicine that plans to offer personalized solutions, is expanding to 7 members, as well as iCarbonX, the company that founded the network.